199 related articles for article (PubMed ID: 21889209)
21. Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE)?
Rudant J; Orsi L; Bonaventure A; Goujon-Bellec S; Corda E; Baruchel A; Bertrand Y; Nelken B; Robert A; Michel G; Sirvent N; Chastagner P; Ducassou S; Rialland X; Hémon D; Leverger G; Clavel J
Leukemia; 2013 Mar; 27(3):746-8. PubMed ID: 22922568
[No Abstract] [Full Text] [Related]
22. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Brown AL; de Smith AJ; Gant VU; Yang W; Scheurer ME; Walsh KM; Chernus JM; Kallsen NA; Peyton SA; Davies GE; Ehli EA; Winick N; Heerema NA; Carroll AJ; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Feingold E; Devidas M; Barcellos LF; Hansen HM; Morimoto L; Kang AY; Smirnov I; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson P; Spector LG; Pombo-de-Oliveira MS; DeWan AT; Mullighan CG; Hunger SP; Pui CH; Loh ML; Zwick ME; Metayer C; Ma X; Mueller BA; Sherman SL; Wiemels JL; Relling MV; Yang JJ; Lupo PJ; Rabin KR
Blood; 2019 Oct; 134(15):1227-1237. PubMed ID: 31350265
[TBL] [Abstract][Full Text] [Related]
23. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951.
Mirebeau D; Acquaviva C; Suciu S; Bertin R; Dastugue N; Robert A; Boutard P; Méchinaud F; Plouvier E; Otten J; Vilmer E; Cavé H;
Haematologica; 2006 Jul; 91(7):881-5. PubMed ID: 16818274
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the Hel-N1 gene in childhood acute lymphoblastic leukemia with LOH at 9p21.
Takeuchi C; Takeuchi S; Ikezoe T; Bartram CR; Koeffler HP; Taguchi H
Leukemia; 1999 Apr; 13(4):650-1. PubMed ID: 10214879
[No Abstract] [Full Text] [Related]
26. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
Quesnel B
Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
[TBL] [Abstract][Full Text] [Related]
27. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Linabery AM; Blommer CN; Spector LG; Davies SM; Robison LL; Ross JA
Leuk Res; 2013 Aug; 37(8):936-42. PubMed ID: 23692655
[TBL] [Abstract][Full Text] [Related]
28. Broad phenotypic spectrum of germ line 7p12.1 microdeletions encompassing the IKZF1 gene includes predisposition to acute lymphoblastic leukemia.
Pastorczak A; Hogendorf A; Urbanska Z; Budzynska E; Jesionek-Kupnicka D; Gach A; Hawula W; Smigiel R; Skiba P; Sasiadek M; Lejman M; Constatinou M; Lipska-Ziętkiewicz BS; Mlynarski W
Genes Chromosomes Cancer; 2021 Feb; 60(2):79-87. PubMed ID: 33135230
[TBL] [Abstract][Full Text] [Related]
29. A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.
Wiemels JL; de Smith AJ; Xiao J; Lee ST; Muench MO; Fomin ME; Zhou M; Hansen HM; Termuhlen A; Metayer C; Walsh KM
Leukemia; 2016 May; 30(5):1194-7. PubMed ID: 26437776
[No Abstract] [Full Text] [Related]
30. Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.
Xu H; Zhang H; Yang W; Yadav R; Morrison AC; Qian M; Devidas M; Liu Y; Perez-Andreu V; Zhao X; Gastier-Foster JM; Lupo PJ; Neale G; Raetz E; Larsen E; Bowman WP; Carroll WL; Winick N; Williams R; Hansen T; Holm JC; Mardis E; Fulton R; Pui CH; Zhang J; Mullighan CG; Evans WE; Hunger SP; Gupta R; Schmiegelow K; Loh ML; Relling MV; Yang JJ
Nat Commun; 2015 Jun; 6():7553. PubMed ID: 26104880
[TBL] [Abstract][Full Text] [Related]
31. NBN and XRCC3 genetic variants in childhood acute lymphoblastic leukaemia.
Smolkova B; Dusinska M; Hemminki K
Cancer Epidemiol; 2014 Oct; 38(5):563-8. PubMed ID: 25176580
[TBL] [Abstract][Full Text] [Related]
32. Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies.
Chrzanowska KH; Piekutowska-Abramczuk D; Popowska E; Gładkowska-Dura M; Małdyk J; Syczewska M; Krajewska-Walasek M; Goryluk-Kozakiewicz B; Bubała H; Gadomski A; Gaworczyk A; Kazanowska B; Kołtan A; Kuźmicz M; Luszawska-Kutrzeba T; Maciejka-Kapuścińska L; Stolarska M; Stefańska K; Sznurkowska K; Wakulińska A; Wieczorek M; Szczepański T; Kowalczyk J
Int J Cancer; 2006 Mar; 118(5):1269-74. PubMed ID: 16152606
[TBL] [Abstract][Full Text] [Related]
33. Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures.
Evans TJ; Milne E; Anderson D; de Klerk NH; Jamieson SE; Talseth-Palmer BA; Bowden NA; Holliday EG; Rudant J; Orsi L; Richardson E; Lavis L; Catchpoole D; Attia JR; Armstrong BK; Clavel J; Scott RJ
PLoS One; 2014; 9(10):e110255. PubMed ID: 25310577
[TBL] [Abstract][Full Text] [Related]
34. Genetic variants in ARID5B and CEBPE are childhood ALL susceptibility loci in Hispanics.
Chokkalingam AP; Hsu LI; Metayer C; Hansen HM; Month SR; Barcellos LF; Wiemels JL; Buffler PA
Cancer Causes Control; 2013 Oct; 24(10):1789-95. PubMed ID: 23836053
[TBL] [Abstract][Full Text] [Related]
35. The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A.
Vijayakrishnan J; Henrion M; Moorman AV; Fiege B; Kumar R; da Silva Filho MI; Holroyd A; Koehler R; Thomsen H; Irving JA; Allan JM; Lightfoot T; Roman E; Kinsey SE; Sheridan E; Thompson PD; Hoffmann P; Nöthen MM; Mühleisen TW; Eisele L; Bartram CR; Schrappe M; Greaves M; Hemminki K; Harrison CJ; Stanulla M; Houlston RS
Sci Rep; 2015 Oct; 5():15065. PubMed ID: 26463672
[TBL] [Abstract][Full Text] [Related]
36. ARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.
Rudant J; Orsi L; Bonaventure A; Goujon-Bellec S; Baruchel A; Petit A; Bertrand Y; Nelken B; Pasquet M; Michel G; Saumet L; Chastagner P; Ducassou S; Réguerre Y; Hémon D; Clavel J
PLoS One; 2015; 10(3):e0121348. PubMed ID: 25806972
[TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of the cell cycle inhibitor Kip1/p27 in childhood leukemia.
Markaki EA; Stiakaki E; Zafiropoulos A; Arvanitis DA; Katzilakis N; Dimitriou H; Spandidos DA; Kalmanti M
Pediatr Blood Cancer; 2006 Jul; 47(1):14-21. PubMed ID: 16526056
[TBL] [Abstract][Full Text] [Related]
38. Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
Sattarzadeh Bardsiri M; Zehtab S; Karami N; Farsinejad A; Ehsan M; Fatemi A
BMC Med Genomics; 2022 Aug; 15(1):171. PubMed ID: 35932035
[TBL] [Abstract][Full Text] [Related]
39. A polymorphism in the chromosome 9p21 ANRIL locus is associated to Philadelphia positive acute lymphoblastic leukemia.
Iacobucci I; Sazzini M; Garagnani P; Ferrari A; Boattini A; Lonetti A; Papayannidis C; Mantovani V; Marasco E; Ottaviani E; Soverini S; Girelli D; Luiselli D; Vignetti M; Baccarani M; Martinelli G
Leuk Res; 2011 Aug; 35(8):1052-9. PubMed ID: 21414664
[TBL] [Abstract][Full Text] [Related]
40. CEBPE polymorphism confers an increased risk of childhood acute lymphoblastic leukemia: a meta-analysis of 11 case-control studies with 5,639 cases and 10,036 controls.
Wang C; Chen J; Sun H; Sun L; Liu Y
Ann Hematol; 2015 Feb; 94(2):181-5. PubMed ID: 25195121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
